Education
About Us
Working with TipRanks
Follow Us
Plandai Biotechnology Inc (PLPL)
OTHER OTC:PLPL
Total Valuation
Plandai Biotechnology has a market cap or net worth of $44.89K. The enterprise value is $4.65M.
Market Cap$44.89K
Enterprise Value$4.65M
Share Statistics
Plandai Biotechnology has 44,889,035,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding44,889,035,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Plandai Biotechnology’s return on equity (ROE) is -291.44 and return on invested capital (ROIC) is -3811.00%.
Return on Equity (ROE)-291.44
Return on Assets (ROA)160.29
Return on Invested Capital (ROIC)-3811.00%
Return on Capital Employed (ROCE)-84.69
Revenue Per Employee0.00
Profits Per Employee89.05K
Employee Count180
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Plandai Biotechnology is ―. Plandai Biotechnology’s PEG ratio is -0.00728.
PE Ratio―
PS Ratio0.00
PB Ratio-244.85
Price to Fair Value-244.85
Price to FCF0.86
Price to Operating Cash Flow0.00
PEG Ratio-0.00728
Income Statement
In the last 12 months, Plandai Biotechnology had revenue of 0.00 and earned 16.03M in profits. Earnings per share was <0.01.
Revenue0.00
Gross Profit0.00
Operating Income-3.81M
Pretax Income16.03M
Net Income16.03M
EBITDA35.88M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was 15.81M and capital expenditures -3.00, giving a free cash flow of 15.81M billion.
Operating Cash Flow15.81M
Free Cash Flow15.81M
Free Cash Flow per Share<0.01
Dividends & Yields
Plandai Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-126.54
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Plandai Biotechnology upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Plandai Biotechnology as a current ratio of 0.00, with Debt / Equity ratio of -270.13%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.01
Net Debt to EBITDA<0.01
Interest Coverage Ratio-841.28
Taxes
In the past 12 months, Plandai Biotechnology has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Plandai Biotechnology EV to EBITDA ratio is 0.38, with an EV/FCF ratio of 0.87.
EV to Sales0.00
EV to EBITDA0.38
EV to Free Cash Flow0.87
EV to Operating Cash Flow0.87
Balance Sheet
Plandai Biotechnology has $0.00 in cash and marketable securities with $155.00K in debt, giving a net cash position of -$155.00K billion.
Cash & Marketable Securities$0.00
Total Debt$155.00K
Net Cash-$155.00K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Plandai Biotechnology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―